Contents

Current Pharmaceutical Design, Volume 10 - Number 32

Editorial [Hot Topic: Anti-HIV Drug Design and Therapy (Executive Editor: Ted M. Ross)]

, 10(32): 4003

Ted M. Ross


DOI: 10.2174/1381612043382486




Anti-HIV Drug Development - An Overview

, 10(32): 4005 - 4037

Candida F. Pereira and Judith T.M.L. Paridaen


DOI: 10.2174/1381612043382459




Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors

, 10(32): 4039 - 4053

Tomozumi Imamichi


DOI: 10.2174/1381612043382440




Acquisition of Multi-PI (Protease Inhibitor) Resistance in HIV-1 In Vivo and In Vitro

, 10(32): 4055 - 4064

Keisuke Yusa and Shinji Harada


DOI: 10.2174/1381612043382477




Drug Resistance, Virus Fitness and HIV-1 Mutagenesis

, 10(32): 4065 - 4070

Renxiang Chen, Miguel E. Quinones-Mateu and Louis M. Mansky


DOI: 10.2174/1381612043382404




Antiretroviral Drugs and The Kidney: Dosage Adjustment and Renal Tolerance

, 10(32): 4071 - 4079

Hassane Izzedine, Vincent Launay-Vacher and Gilbert Deray


DOI: 10.2174/1381612043382431




Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance

, 10(32): 4081 - 4101

Veronic Marie Isabelle Provencher, Ersilia Coccaro, Jonathan Jacques Lacasse and Luis Maria Schang


DOI: 10.2174/1381612043382422




“Virostatics” as a Potential New Class of HIV Drugs

, 10(32): 4103 - 4120

L. M. Kelly, J. Lisziewicz and F. Lori


DOI: 10.2174/1381612043382495




Cellular Physiology of Mismatch Repair

, 10(32): 4121 - 4126

X. Wu, Z. Khalpey and M. Cascalho


DOI: 10.2174/1381612043382468




Current Biological Therapies for Inflammatory Bowel Disease

, 10(32): 4127 - 4147

Daniel C. Baumgart and Axel U. Dignass


DOI: 10.2174/1381612043382413




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science